Vimarsana
Biggest News Aggregation in the World

Due Berg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Due Berg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Due Berg Today - Breaking & Trending Today

Novo Nordisk A/S: Novo Nordisk's net profit increased by 6% in the first three months of 2021 - Vimarsana News

Novo Nordisk A/S: Novo Nordisk's net profit increased by 6% in the first three months of 2021

Novo Nordisk A/S: Novo Nordisk's net profit increased by 6% in the first three months of 2021 Operating profit decreased by 8% in Danish kroner and increased by 3% at constant exchange rates (CER). Sales remained unchanged in Danish kroner and increased by 7% at CER to DKK 33.8 billion. Sales in International Operations increased by 2% in Danish kroner (9% at CER), and sales in North America Operations decreased by 3% in Danish kroner (increased 6% at CER). Sales growth is negatively impacted by COVID-19-related stocking in 2020, partially offset by inventory changes and timing of shipments i...

Novo Nordisk A/S: Novo Nordisk to initiate phase 3a development in obesity with oral semaglutide - Vimarsana News

Novo Nordisk A/S: Novo Nordisk to initiate phase 3a development in obesity with oral semaglutide

Novo Nordisk A/S: Novo Nordisk to initiate phase 3a development in obesity with oral semaglutide 21 April 2021 - Novo Nordisk today announced the decision to enter phase 3a development in obesity with oral semaglutide 50 mg. The decision follows the completion of the STEP phase 3a clinical programme with once-weekly subcutaneous (sc) semaglutide 2.4 mg. Novo Nordisk intends to initiate a pivotal phase 3a programme with approximately 1,000 people with obesity or overweight with comorbidities. The global 68-week trial is planned for initiation in the second half of 2021 and will investigate th...

Novo Nordisk's net profit increased by 8% in 2020 - Vimarsana News

Novo Nordisk's net profit increased by 8% in 2020

Novo Nordisk's net profit increased by 8% in 2020 Novo Nordisk A/S Financial report for the period 1 January 2020 to 31 December 2020 Sales increased by 4% in Danish kroner and by 7% at CER to DKK 126.9 billion. Sales in International Operations increased by 7% in Danish kroner (10% at CER), and sales in North America Operations increased by 1% in Danish kroner (3% at CER). Sales growth was negatively impacted by COVID-19, driven by fewer patients initiating treatment. Sales within Diabetes and Obesity care increased by 5% to DKK 108.0 billion (8% at CER), driven by GLP-1 growth of 26% in...

Novo Nordisk A/S: Novo Nordisk to enter phase 3 development in Alzheimer's disease with oral semaglutide - Vimarsana News

Novo Nordisk A/S: Novo Nordisk to enter phase 3 development in Alzheimer's disease with oral semaglutide

(2) Bagsværd, Denmark, 16 December 2020 - Novo Nordisk today announced the decision to enter phase 3 development in Alzheimer's disease with 14 mg oral semaglutide, a once-daily oral formulation of the long-acting GLP-1 analogue semaglutide. The decision follows evaluation of GLP-1 data from preclinical models, real-world evidence studies, post-hoc analysis of data from large cardiovascular outcomes trials, as well as discussions with regulatory authorities. Novo Nordisk intends to initiate a pivotal phase 3a programme with approximately 3,700 people with early Alzheimer's disease. The progr...